Video Experimental Relacionado
Updated: Jun 24, 2025

04:11
A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
16.9K
La plasticidad de la mielina en el área tegmental ventral se requiere para la recompensa opioide
Belgin Yalçın1, Matthew B Pomrenze2, Karen Malacon1
1Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Nature
|June 5, 2024
Resumen
Plasticidad de la mielina en el cerebro
Área de la Ciencia:
- La neurociencia
- Biología celular
- Investigación de las adicciones
Sus antecedentes:
- Las drogas de abuso causan cambios duraderos en los circuitos neuronales, que conducen a trastornos por consumo de sustancias.
- Los cambios de mielina regulados por la actividad son un mecanismo recientemente reconocido para afinar la función del circuito neuronal y el comportamiento cognitivo.
Objetivo del estudio:
- Investigar el papel de la plasticidad de la mielina en los circuitos dopaminérgicos y el aprendizaje de la recompensa.
- Comprender cómo las respuestas oligodendrogliales a la actividad neuronal afectan la recompensa de los opioides.
Principales métodos:
- Estimulación optogenética de las neuronas dopaminérgicas y GABAérgicas.
- La administración de morfina.
- Bloqueo genético de la oligodendrogénesis.
- Medición de la dinámica de liberación de dopamina.
- Pruebas de condicionamiento del comportamiento.
Principales resultados:
- Las células del linaje oligodendroglial en el área tegmental ventral responden a la actividad neuronal dopaminérgica.
- Estos cambios en la mielina son específicos del área tegmental ventral.
- El bloqueo de la oligodendrogénesis perjudica la recompensa de la morfina y la dinámica de liberación de dopamina.
Conclusiones:
- La oligodendrogénesis juega un papel crítico en el aprendizaje de la recompensa.
- La plasticidad de la mielina regulada por la actividad neuronal dopaminérgica es esencial para la recompensa opioide.
Videos de Conceptos Relacionados
Analgesia and Pain Management
579
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
579
Opioid Receptors: Overview
729
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
729
Drug Abuse and Addiction: Pharmacological Phenomena
465
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
465
Neuroplasticity
325
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
325

